サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1551480

アルコール性肝炎治療の世界市場

Alcoholic Hepatitis Treatment

出版日
ページ情報
英文 265 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
アルコール性肝炎治療の世界市場
出版日: 2024年09月10日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 265 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

アルコール性肝炎治療の世界市場は2030年までに30億米ドルに到達

2023年に22億米ドルと推定されるアルコール性肝炎治療の世界市場は、分析期間2023～2030年にCAGR 4.4%で成長し、2030年には30億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである副腎皮質ステロイドは、CAGR 4.4%を記録し、分析期間終了時には17億米ドルに達すると予測されます。痔疾治療薬セグメントの成長率は、分析期間中CAGR 3.9％と推定されます。

米国市場は推定6億310万米ドル、中国はCAGR7.3％で成長予測

米国のアルコール性肝炎治療市場は2023年に6億310万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけてCAGR 7.3%で推移し、2030年には6億870万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と4.7%と予測されています。欧州では、ドイツがCAGR 2.6%で成長すると予測されています。

世界のアルコール性肝炎治療市場- 主要動向と促進要因のまとめ

アルコール性肝炎治療の主要なアプローチとは？

アルコール性肝炎は、アルコールの過剰摂取によって引き起こされる肝臓の重篤な炎症状態であり、治療には多面的なアプローチが求められます。第一の戦略は、アルコール摂取を直ちに中止することであり、これはさらなる肝障害を食い止めるために極めて重要です。多くの場合、医学的介入は支持療法から始まり、患者の間で広くみられる症状や栄養不良などの合併症に対処します。栄養サポート、特にタンパク質とビタミンの補給は、肝機能と患者全体の健康を改善するために不可欠です。プレドニゾロンなどの副腎皮質ステロイドは、重症例では肝臓の炎症を抑えるために一般的に使用されます。しかし、副腎皮質ステロイドの有効性は様々であり、免疫不全患者における感染症のリスクのために、その使用はしばしば議論されます。また、肝移植が必要となる肝不全などの合併症の管理も重要な治療です。アルコール性肝炎治療の複雑性から、患者の全身状態、疾患の重症度、併存疾患を考慮した個別のケアプランの必要性が浮き彫りになります。

新たな調査は、アルコール性肝炎治療の進歩にどのような役割を果たすのでしょうか？

新たな調査は、病気のメカニズムや潜在的な治療標的に関する新たな洞察を提供し、アルコール性肝炎治療の状況を一変させています。アルコール性肝炎の原因となる分子的・遺伝的要因の解明が進み、病気の進行を修正することを目的とした新しい治療法の開発が進んでいます。例えば、腸-肝軸相互作用の研究により、腸内細菌叢がアルコール性肝炎の発症と重症化に重要な役割を果たしていることが明らかになった。このため、潜在的な治療介入としてプロバイオティクスや糞便微生物叢移植の研究が進められています。さらに、肝臓の炎症に関与する特定の免疫経路を標的とする免疫療法が、アルコール性肝炎の有望な治療法として注目されています。現在、IL-1阻害剤やTNF-α遮断剤など、肝臓の炎症を抑え、患者の予後を改善する可能性を示した様々な生物学的製剤の有効性を評価する臨床試験が進行中です。この分野における研究開発の急速なペースは、近い将来、より効果的で個別化された治療法の選択肢をもたらすと期待されています。

ヘルスケアシステムはアルコール性肝炎の課題にどのように取り組んでいるか？

アルコール性肝炎は複雑な疾患であり、アルコール乱用が多いことが主な原因です。主な課題のひとつは、アルコール性肝炎の早期診断です。アルコール性肝炎はしばしば非特異的な症状を呈し、他の肝臓疾患と間違われることがあるからです。この問題に対処するため、ヘルスケアプロバイダーは早期発見と予後を改善するために、非侵襲的画像診断技術やバイオマーカーを含む高度な診断ツールの活用をますます進めています。さらに、患者に包括的なケアを提供するために、肝臓専門医、栄養士、心理学者、ソーシャルワーカーを含む集学的ケアチームを統合することが重視されるようになってきています。このアプローチにより、治療から心理社会的サポートに至るまで、疾患のあらゆる側面に確実に対処することができます。さらに、ヘルスケアシステムは、アルコール性肝炎の発症率を下げるために、公衆衛生キャンペーンや禁酒プログラムなどの予防対策に力を入れています。こうした取り組みは、過度のアルコール摂取のリスクに関する認識を高め、アルコール中毒に悩む人々にリソースを提供することを目的としています。

アルコール性肝炎治療市場の成長の原動力は？

アルコール性肝炎治療市場の成長は、テクノロジーの進歩、消費者行動の変化、ヘルスケアプラクティスの進化を反映するいくつかの要因によって牽引されています。主な要因の一つは、世界のアルコール使用障害（AUD）の有病率の増加であり、これによってアルコール性肝炎の発生率が高まり、その結果、効果的な治療に対する需要が高まっています。診断と治療における技術的進歩も市場成長に寄与しています。非侵襲的肝画像診断、次世代シーケンシング、精密医療などの技術革新は、より正確な診断と個別化された治療アプローチを可能にし、それによって患者の転帰を改善し、市場を拡大しています。もう1つの重要な要因は、アルコール性肝炎の重症例に対する実行可能な治療オプションとして肝移植に対する認識と受容が高まっていることであり、これは手術手技と移植後のケアの改善に支えられています。さらに、患者のモニタリングや治療プロトコルの遵守を強化するために、遠隔医療やモバイルヘルスアプリなどのデジタルヘルスソリューションの統合が重視されるようになっています。早期介入と包括的ケアへの関心の高まりと相まって、こうした技術的発展がアルコール性肝炎治療市場の拡大を促進する主な要因となっています。

調査対象企業の例（注目の25社）

  • Aldeyra Therapeutics, Inc
  • Anuh Pharma Ltd
  • Arrowhead Pharmaceuticals Inc.
  • Cation Chemical
  • Cipla
  • Durect Corporation
  • Evive Biotech
  • HighTide Therapeutics, Inc.
  • Hovione
  • Nordic Bioscience A/S
  • Steroid SpA
  • Surrozen, Inc.
  • Symbiotec Pharmalab
  • Taj Pharma Group
  • ZyVersa Therapeutics, Inc.;

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP26730

Global Alcoholic Hepatitis Treatment Market to Reach US$3.0 Billion by 2030

The global market for Alcoholic Hepatitis Treatment estimated at US$2.2 Billion in the year 2023, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Corticosteroids, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Hemorrheologic Agents segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$603.1 Million While China is Forecast to Grow at 7.3% CAGR

The Alcoholic Hepatitis Treatment market in the U.S. is estimated at US$603.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$608.7 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Alcoholic Hepatitis Treatment Market - Key Trends and Drivers Summarized

What Are the Key Approaches in Alcoholic Hepatitis Treatment?

Alcoholic hepatitis, a severe inflammatory condition of the liver caused by excessive alcohol consumption, demands a multifaceted approach to treatment. The primary strategy focuses on immediate cessation of alcohol intake, which is crucial for halting further liver damage. Medical interventions often begin with supportive care, addressing the symptoms and complications such as malnutrition, which is prevalent among patients. Nutritional support, particularly protein and vitamin supplementation, is vital for improving liver function and overall patient health. Corticosteroids, such as prednisolone, are commonly used to reduce liver inflammation in severe cases. However, the effectiveness of corticosteroids can vary, and their use is often debated due to the risk of infections in immunocompromised patients. Another critical treatment aspect is managing complications such as liver failure, which may require liver transplantation. The complexity of alcoholic hepatitis treatment highlights the need for individualized care plans, which consider the patient's overall health, the severity of the disease, and any coexisting conditions.

What Role Does Emerging Research Play in Advancing Alcoholic Hepatitis Treatment?

Emerging research is transforming the landscape of alcoholic hepatitis treatment, offering new insights into disease mechanisms and potential therapeutic targets. Advances in understanding the molecular and genetic factors that contribute to alcoholic hepatitis have led to the development of novel therapies aimed at modifying disease progression. For instance, research into gut-liver axis interactions has revealed that gut microbiota plays a significant role in the development and severity of alcoholic hepatitis. This has prompted studies on probiotics and fecal microbiota transplantation as potential therapeutic interventions. Additionally, immunotherapy is gaining attention as a promising avenue for treating alcoholic hepatitis by targeting specific immune pathways involved in liver inflammation. Clinical trials are currently underway to evaluate the efficacy of various biologics, such as IL-1 inhibitors and TNF-alpha blockers, which have shown potential in reducing liver inflammation and improving patient outcomes. The rapid pace of research and development in this field holds promise for more effective and personalized treatment options in the near future.

How Are Healthcare Systems Addressing the Challenges of Alcoholic Hepatitis?

Healthcare systems worldwide face significant challenges in managing alcoholic hepatitis, largely due to the disease's complex nature and the high prevalence of alcohol abuse. One of the primary challenges is the early diagnosis of alcoholic hepatitis, as the disease often presents with non-specific symptoms that can be mistaken for other liver conditions. To address this, healthcare providers are increasingly utilizing advanced diagnostic tools, including non-invasive imaging techniques and biomarkers, to improve early detection and prognosis. Moreover, there is a growing emphasis on integrating multidisciplinary care teams, including hepatologists, nutritionists, psychologists, and social workers, to provide comprehensive care for patients. This approach ensures that all aspects of the disease, from medical treatment to psychosocial support, are addressed. Additionally, healthcare systems are focusing on preventive measures, such as public health campaigns and alcohol cessation programs, to reduce the incidence of alcoholic hepatitis. These initiatives aim to raise awareness about the risks of excessive alcohol consumption and provide resources for individuals struggling with alcohol addiction.

What Is Driving Growth in the Alcoholic Hepatitis Treatment Market?

The growth in the alcoholic hepatitis treatment market is driven by several factors that reflect advancements in technology, changing consumer behavior, and evolving healthcare practices. One of the primary drivers is the increasing prevalence of alcohol use disorder (AUD) worldwide, which has led to a higher incidence of alcoholic hepatitis and, consequently, a greater demand for effective treatments. Technological advancements in diagnostics and therapeutics are also contributing to market growth. Innovations such as non-invasive liver imaging, next-generation sequencing, and precision medicine are enabling more accurate diagnosis and personalized treatment approaches, thereby improving patient outcomes and expanding the market. Another significant factor is the rising awareness and acceptance of liver transplantation as a viable treatment option for severe cases of alcoholic hepatitis, supported by improvements in surgical techniques and post-transplant care. Furthermore, there is a growing emphasis on integrating digital health solutions, such as telemedicine and mobile health apps, to enhance patient monitoring and adherence to treatment protocols. These technological developments, coupled with an increasing focus on early intervention and comprehensive care, are key drivers propelling the expansion of the alcoholic hepatitis treatment market.

Select Competitors (Total 25 Featured) -

  • Aldeyra Therapeutics, Inc
  • Anuh Pharma Ltd
  • Arrowhead Pharmaceuticals Inc.
  • Cation Chemical
  • Cipla
  • Durect Corporation
  • Evive Biotech
  • HighTide Therapeutics, Inc.
  • Hovione
  • Nordic Bioscience A/S
  • Steroid SpA
  • Surrozen, Inc.
  • Symbiotec Pharmalab
  • Taj Pharma Group
  • ZyVersa Therapeutics, Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Alcoholic Hepatitis Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Alcohol Use Disorders Expands Addressable Market Opportunity for Alcoholic Hepatitis Treatment
    • Advancements in Immunotherapy Propel Growth in Targeted Alcoholic Hepatitis Treatment Options
    • Focus on Early Diagnosis and Intervention Drives Adoption of Innovative Therapeutic Approaches
    • Development of Biologics and Regenerative Medicine Strengthens Business Case for Next-Generation Alcoholic Hepatitis Treatments
    • Integration of Personalized Medicine and Genomic Insights Throws the Spotlight on Tailored Treatment Strategies
    • Growing Awareness and Screening Initiatives Spur Growth in Preventive and Early-Stage Treatment Solutions
    • Rising Healthcare Expenditure and Access to Advanced Care Generate Demand for Premium Alcoholic Hepatitis Therapies
    • Challenges in Managing Severe Cases Present Opportunities for Innovation in Combination Therapy Approaches
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Alcoholic Hepatitis Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Alcoholic Hepatitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Alcoholic Hepatitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Corticosteroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hemorrheologic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hemorrheologic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hemorrheologic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Anabolic Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Anabolic Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Anabolic Steroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • JAPAN
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • CHINA
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • EUROPE
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Alcoholic Hepatitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Alcoholic Hepatitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • FRANCE
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • GERMANY
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Alcoholic Hepatitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Alcoholic Hepatitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • INDIA
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Alcoholic Hepatitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Alcoholic Hepatitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Alcoholic Hepatitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Alcoholic Hepatitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • AFRICA
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030

IV. COMPETITION